List of Excipients in API VORINOSTAT
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing VORINOSTAT
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Merck Sharp & Dohme LLC | ZOLINZA | vorinostat | 0006-0568 | CELLULOSE, MICROCRYSTALLINE | 2027-03-11 |
Merck Sharp & Dohme LLC | ZOLINZA | vorinostat | 0006-0568 | CROSCARMELLOSE SODIUM | 2027-03-11 |
Merck Sharp & Dohme LLC | ZOLINZA | vorinostat | 0006-0568 | GELATIN | 2027-03-11 |
Merck Sharp & Dohme LLC | ZOLINZA | vorinostat | 0006-0568 | MAGNESIUM STEARATE | 2027-03-11 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for VORINOSTAT
Excipient focus: CELLULOSE, MICROCRYSTALLINE
VORINOSTAT drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | vorinostat | 0006-0568 |
>Company | >Ingredient | >NDC |
VORINOSTAT drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
VORINOSTAT drug variants containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | vorinostat | 0006-0568 |
>Company | >Ingredient | >NDC |
VORINOSTAT drug variants not containing CROSCARMELLOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
VORINOSTAT drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | vorinostat | 0006-0568 |
>Company | >Ingredient | >NDC |
VORINOSTAT drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
VORINOSTAT drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | vorinostat | 0006-0568 |
>Company | >Ingredient | >NDC |
VORINOSTAT drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
VORINOSTAT drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | vorinostat | 0006-0568 |
>Company | >Ingredient | >NDC |
VORINOSTAT drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
VORINOSTAT drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Merck Sharp & Dohme LLC | vorinostat | 0006-0568 |
>Company | >Ingredient | >NDC |
VORINOSTAT drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.